- Home
- TWLO vs PODD Comparison
TWLO vs PODD Comparison
Compare TWLO & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWLO
- PODD
- Stock Information
- Founded
- TWLO 2008
- PODD 2000
- Country
- TWLO United States
- PODD United States
- Employees
- TWLO N/A
- PODD N/A
- Industry
- TWLO Computer Software: Prepackaged Software
- PODD Medical/Dental Instruments
- Sector
- TWLO Technology
- PODD Health Care
- Exchange
- TWLO Nasdaq
- PODD Nasdaq
- Market Cap
- TWLO 19.2B
- PODD 16.5B
- IPO Year
- TWLO 2016
- PODD 2007
- Fundamental
- Price
- TWLO $114.31
- PODD $282.80
- Analyst Decision
- TWLO Buy
- PODD Buy
- Analyst Count
- TWLO 23
- PODD 16
- Target Price
- TWLO $131.26
- PODD $291.81
- AVG Volume (30 Days)
- TWLO 5.1M
- PODD 574.3K
- Earning Date
- TWLO 02-13-2025
- PODD 02-20-2025
- Dividend Yield
- TWLO N/A
- PODD N/A
- EPS Growth
- TWLO N/A
- PODD 96.40
- EPS
- TWLO N/A
- PODD 5.78
- Revenue
- TWLO $4,458,036,000.00
- PODD $2,071,600,000.00
- Revenue This Year
- TWLO $9.91
- PODD $23.56
- Revenue Next Year
- TWLO $8.14
- PODD $18.07
- P/E Ratio
- TWLO N/A
- PODD $48.93
- Revenue Growth
- TWLO 7.32
- PODD 22.07
- 52 Week Low
- TWLO $52.51
- PODD $160.19
- 52 Week High
- TWLO $151.95
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- TWLO 33.28
- PODD 54.94
- Support Level
- TWLO $139.60
- PODD $270.00
- Resistance Level
- TWLO $147.42
- PODD $288.95
- Average True Range (ATR)
- TWLO 4.91
- PODD 6.83
- MACD
- TWLO -4.67
- PODD -0.31
- Stochastic Oscillator
- TWLO 3.77
- PODD 65.78
About TWLO Twilio Inc.
Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.